| id | Study | Lib. in paper | Exposition period | Study type |
Control type |
Tags | OR 95%CI | x1/n1 x0/n0 | no cases | no exposed | ROB | Ref. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| S19381 R82468 |
Straub (Controls exposed to LTG) (Phenytoin) (Epilepsy), 2026 | Autism spectrum disorder - ICD-10 codes: F84.x (except F84.2, F84.3) - Mean follow up (full cohort): 3.4 years | during pregnancy (anytime or not specified) | retrospective cohort (claims database) | exposed to other treatment, sick excluded | Adjustment: No |
0.90 [0.47;1.71] C excluded (control group) |
13/1,390 34/3,273 | 47 | 1,390 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S19370 R82475 |
Straub (Controls unexposed, sick) (Phenytoin) (Epilepsy), 2026 | Autism spectrum disorder - ICD-10 codes: F84.x (except F84.2, F84.3) - Mean follow up (full cohort): 3.4 years | during pregnancy (anytime or not specified) | retrospective cohort (claims database) | unexposed, sick | Adjustment: Yes | 0.54 [0.29;0.98] | 13/1,390 106/8,887 | 119 | 1,390 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S17390 R72908 |
Madley-Dowd_SE (Phenytoin) (Controls exposed to LTG) (Mixed indications), 2024 | Autism - ICD-8/9/10 codes - Mean 5-20 years old (according groups) | during pregnancy (anytime or not specified) | population based cohort retrospective | exposed to other treatment, sick excluded | Adjustment: Yes |
1.18 [0.62;2.24] excluded (control group) |
10/194 134/5,035 | 144 | 194 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S17391 R72914 |
Madley-Dowd_SE (Phenytoin) (Controls unexposed, general pop) (Mixed indications), 2024 | Autism - ICD-8/9/10 codes - Mean 5-20 years old (according groups) | during pregnancy (anytime or not specified) | population based cohort retrospective | unexposed (general population or NOS) | Adjustment: Yes | 0.97 [0.52;1.82] | 10/194 68,788/2,651,210 | 68,798 | 194 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S17392 R72920 |
Madley-Dowd_SE (Phenytoin) (Controls unexposed, sibling) (Mixed indications), 2024 | Autism - ICD-8/9/10 codes - Mean 5-20 years old (according groups) | during pregnancy (anytime or not specified) | population based cohort retrospective | sibling excluded | Adjustment: Yes |
5.34 [0.70;40.88] excluded (control group) |
-/- -/- | - | - |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S17283 R72392 |
Madley-Dowd_UK (Phenytoin) (Controls exposed to LTG) (Mixed indications), 2024 | Autism - ICD10 codes - Median follow up 10.75 (7.82-13.62) years old | during pregnancy (anytime or not specified) | retrospective cohort (claims database) | exposed to other treatment, sick excluded | Adjustment: Yes |
1.09 [0.15;7.66] excluded (control group) |
-/46 20/939 | - | 46 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S17268 R72393 |
Madley-Dowd_UK (Phenytoin) (Controls unexposed, general pop) (Mixed indications), 2024 | Autism - ICD10 codes - Median follow up 10.75 (7.82-13.62) years old | during pregnancy (anytime or not specified) | retrospective cohort (claims database) | unexposed (general population or NOS) | Adjustment: Yes | 1.19 [0.18;8.05] | -/46 7,657/514,066 | - | 46 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S17276 R72394 |
Madley-Dowd_UK (Phenytoin) (Controls unexposed, sibling) (Mixed indications), 2024 | Autism - ICD10 codes - Median follow up 10.75 (7.82-13.62) years old | during pregnancy (anytime or not specified) | retrospective cohort (claims database) | sibling excluded | Adjustment: Yes |
15.33 [4.45;52.85] excluded (control group) |
-/- -/- | - | - |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S9256 R48804 |
Bromley (Phenytoin) (Controls exposed to Lamotrigine, sick), 2008 | Autism spectrum disorder (a majority aged 6 and above) | early pregnancy | prospective cohort | exposed to other treatment, sick excluded | Adjustment: No |
5.38 [0.30;95.06] C excluded (control group) |
1/9 1/44 | 2 | 9 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S9257 R48805 |
Bromley (Phenytoin) (Controls unexposed, disease free), 2008 | Autism spectrum disorder (a majority aged 6 and above) | early pregnancy | prospective cohort | unexposed, disease free excluded | Adjustment: No |
13.88 [1.30;148.33] C excluded (control group) |
1/9 3/336 | 4 | 9 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S9258 R48806 |
Bromley (Phenytoin) (Controls unexposed, sick), 2008 | Autism spectrum disorder (a majority aged 6 and above) | early pregnancy | prospective cohort | unexposed, sick | Adjustment: No | 18.60 [0.69;500.42] C | 1/9 0/47 | 1 | 9 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total | 4 studies | 0.88 [0.43;1.80] | 68,918 | 1,639 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1: Controls unexposed, sick) (Phenytoin) (Epilepsy; 2: Phenytoin) (Controls unexposed, general pop) (Mixed indications; 3: Phenytoin) (Controls unexposed, general pop) (Mixed indications; 4: Phenytoin) (Controls unexposed, sick;
Asymetry test p-value = NaN (by Egger's regression)
not enought points
excluded 9256, 9257, 17390, 17392, 17283, 17276, 19381